Biocellvia

We develop intelligent image analysis for the pharmaceutical industry in the context of drug discovery. Our tests are available for #IPF and #NASH (#Fibrosis)

[Sowefund @sowefund]

Vous pouvez toujours investir dans la startup @Biocellvia, découvrez le dernier article des @LesEchos sur cette #biotech
#startup #entrepreneuriat #crowdfunding

[Biocellvia @Biocellvia]

@LesEchos parlent de nous ! Ils mettent en avant notre technologie et parlent de son succès mondial. Pour les #investisseurs intéressés, nous sommes toujours en levée de fonds. C'est ici que ça se passe : https://t.co/vjnfqfGfVF

[European Liver Patients' Association @EuropeLiver]

ELPA president @Marko_Korenjak is part of Paris #NASH meeting. He will address to the participants in panel 1, session 1 on patient view of #NAFLD and #NASH. @NASH_Education @intNASHday @nash24x7 @EU_Health @WHO_Europe

[European Liver Patients' Association @EuropeLiver]

Prof. Serfaty addressing the participants of Paris
#NASHmeeting. @Marko_Korenjak #NAFLD #NASH. @NASH_Education @intNASHday @nash24x7 @EU_Health @WHO_Europe

[Gisli Jenkins @IPFdoc]

@phil_newsome7 describing strategies to treat Liver fibrosis. So many similarities with trying to #CureIPF. List of current therapies being tried in NASH & NAFLD. ?roles in #IPF. Also more good news about #coffee!

[Biocellvia @Biocellvia]

Thanks a lot @cci_paca for this nice article about @Biocellvia
#startup #medtech #biotech #technology #innovation #science #biology #invest #investment #equity #crowdequity

[CCI Provence-Alpes-Côte d'Azur @cci_paca]

[ACTU] #SuccessStory : au moment où la #TeamFranceExport en #regionSud lance le Business Starter 2019 à San Francisco & San Diego, Olivier Julé, CEO de @Biocellvia réalise son rêve californien https://t.co/T8kp7Vb83M #MedTech #BioTech #International

[Biocellvia @Biocellvia]

On this International NASH Day, Biocellvia wants to highlight its own involvment in the research to fight this disease.
More info on : https://t.co/7wLOBzhIYX
#NASH #NASHdisease #InternationalNASHday #NAFLD #NASHday #liver #biotech #medtech #pharma #obesity #diabete #startup

[Biocellvia @Biocellvia]

We are doing a NASH quantitative analysis by quantifying with considerable accuracy the three key parameters of this pathology: steatosis, fibrosis and inflammation.
More info on : https://t.co/id5E8u8LEG
#EASL #AASLD #ILC2019 #NASH #NAFLD #steatosis #fibrosis #inflammation

[Biocellvia @Biocellvia]

Our article on the digital analysis of Idiopathic Pulmonary Fibrosis (IPF) is often quoted. There has been a significant impact which is yet another sign the scientific community is interested in our technology.
More info on : https://t.co/N5bDqnLCFG

[Biocellvia @Biocellvia]

Thanks a lot @EnyoPharma

[ENYO Pharma @EnyoPharma]

It is a great opportunity for ENYO pharma to work with Biocellvia!

[Biocellvia @Biocellvia]

Biocellvia met today leaders from Californian pharma companies. That was a great moment ! #innovation #tech #pharma #startup #medtech #biotech #histology #digital #image #analysis #health

[Invest in Provence @ProvencePromo]

[ #SudBusinessTour #Provence ] Entreprises et acteurs économiques de Californie découvrent l'écosystème de l’#innovation de la métropole Aix-Marseille Provence En visite depuis plusieurs jours sur la région Sud, ils seront demain à Marseille. https://t.co/TJ7n0hbS7b

[Sowefund @sowefund]

Rejoignez l'aventure @Biocellvia et investissez à partir de 100€ dans cette #startup #biotech sur @sowefund : https://t.co/ScxKUnaMeM

[Biocellvia @Biocellvia]

You can invest in Biocellvia with Sowefund by clicking here : https://t.co/vjnfqfGfVF

#crowdequity #fundraising #crowdfunding #funding #startup #biotech #medtech #pharma #frenchtech #tech

[Biocellvia @Biocellvia]

We’ve already announced three new references since the beginning of the year... And there’s more coming!
https://t.co/ansOFfd9Ut

[Biocellvia @Biocellvia]

Olivier Julé presented yesterday Biocellvia's fundraising activity in Paris in front of dozens of investors and business angels.
To invest in Biocellvia : https://t.co/b6pzS0Wgj1

#startup #fundraising #equity #crowdequity #crowdfunding #invest #investment #biotech #medtech

[Biocellvia @Biocellvia]

That's great news for us ! Discover our other public references by clicking on the picture : https://t.co/ZfUivP4Tob

#reference #startup #biotech #medtech #NASH #NAFLD #NashSummit #EASL #ILC2019 #pharma #liver #disease

[Yury Popov //yurypopov.bsky.social @YuryPopovsays]

I’ll be speaking today at #NASHSummit in Boston on “Understanding HCC as an extension of NASH: practical implications for drug development”. Hope to see some of you there! #HCC #NASH

[Biocellvia @Biocellvia]

That's great news for us ! Discover our other public references by clicking on the picture : https://t.co/ZfUivP4Tob

#reference #startup #client #pharma #biotech #medtech #NASH #IPF #ILC19 #liver #lung #pulmonary #fibrosis #fatty #disease

[Biocellvia @Biocellvia]

Tomorrow, we will present a poster with Pr. Isabelle Leclercq from University of Louvain about #NAFLD / #NASH at the International Liver Congress in Vienna. #ILC19 #ILC2019 #EASL #Liver #disease

[Biocellvia @Biocellvia]

We are attending the International Liver Congress. Today is full of meetings, but if you want to meet us, we can book a slot ! #ILC2019 #EASL #Liver #NASH #NAFLD #Digital #Imaging #Histology